Radiopharm Theranostics (RADX) Receivables (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Radiopharm Theranostics (RADX) has disclosed Receivables for 2 consecutive years, with $10.4 million as the latest value for Q2 2025.

• Quarterly Receivables rose 953.26% to $10.4 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $10.4 million through Jun 2025, up 953.26% year-over-year, with the annual reading at $10.4 million for FY2025, 953.26% up from the prior year.
• Receivables for Q2 2025 was $10.4 million at Radiopharm Theranostics, up from $987413.0 in the prior quarter.
• The five-year high for Receivables was $10.4 million in Q2 2025, with the low at $987413.0 in Q2 2024.

Peer Comparison